Clinical trial
Eltrombopag for Patients With Fanconi Anemia
NCT03206086 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Eltrombopag for Patients With Fanconi Anemia
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- November 2, 2018
- Completion date
- August 1, 2028
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.